Episenta 150 mg Prolonged-release Granules

Manufacturer/MA Holder: DESITIN ARZNEIMITTEL GMBH
MA Number: PL 14040/0024

Important information

Please refer to the MHRA PREVENT Programme.

Drug Safety Category

2

Active Ingredient

Valproate (Sodium Valporate, Valproic Acid, Valproate Semisodium)

Formulation

Prolonged Release Granules

Strength

150mg

Licensed for use with feeding tube

No

Confirmed as carbohydrate free

Yes

Length/Diameter

2mm

SPC URL

Open SPC

Excipients of concern

Sodium ContentUndisclosed